Altered Proinflammatory Responses to Polyelectrolyte Multilayer Coatings Are Associated with Differences in Protein Adsorption and Wettability
Source abstract
Abstract
A full understanding of the relationship between surface properties, protein adsorption, and immune responses is lacking but is of great interest for the design of biomaterials with desired biological profiles. In this study, polyelectrolyte multilayer (PEM) coatings with gradient changes in surface wettability were developed to shed light on how this impacts protein adsorption and immune response in the context of material biocompatibility. The analysis of immune responses by peripheral blood mononuclear cells to PEM coatings revealed an increased expression of proinflammatory cytokines tumor necrosis factor (TNF)-α, macrophage inflammatory protein (MIP)-1β, monocyte chemoattractant protein (MCP)-1, and interleukin (IL)-6 and the surface marker CD86 in response to the most hydrophobic coating, whereas the most hydrophilic coating resulted in a comparatively mild immune response. These findings were subsequently confirmed in a cohort of 24 donors. Cytokines were produced predominantly by monocytes with a peak after 24 h. Experiments conducted in the absence of serum indicated a contributing role of the adsorbed protein layer in the observed immune response. Mass spectrometry analysis revealed distinct protein adsorption patterns, with more inflammation-related proteins (e.g., apolipoprotein A-II) present on the most hydrophobic PEM surface, while the most abundant protein on the hydrophilic PEM (apolipoprotein A-I) was related to anti-inflammatory roles. The pathway analysis revealed alterations in the mitogen-activated protein kinase (MAPK)-signaling pathway between the most hydrophilic and the most hydrophobic coating. The results show that the acute proinflammatory response to the more hydrophobic PEM surface is associated with the adsorption of inflammation-related proteins. Thus, this study provides insights into the interplay between material wettability, protein adsorption, and inflammatory response and may act as a basis for the rational design of biomaterials.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Knee injuries and reconstruction techniques · Orthopedic Infections and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany
Department of Biomedical Engineering, Eberhard Karls University Tübingen, 72076 Tübingen, Germany
Faculty of Applied Chemistry, Reutlingen University, 72762 Reutlingen, Germany
Funding
EU-EFRE · State Ministry of Baden-Wuerttemberg for Economic Affairs, Labour and Tourism
References (70)
Show source-provided references
1. 10.1146/annurev.matsci.31.1.8110.1146/annurev.matsci.31.1.81 ↗
2. 10.1016/j.smim.2007.11.00410.1016/j.smim.2007.11.004 ↗
3. 10.1016/j.biomaterials.2008.04.02310.1016/j.biomaterials.2008.04.023 ↗
4. 10.1016/j.biomaterials.2011.05.07810.1016/j.biomaterials.2011.05.078 ↗
5. 10.1039/c4bm00375f10.1039/c4bm00375f ↗
6. 10.1146/annurev-bioeng-071811-15012410.1146/annurev-bioeng-071811-150124 ↗
7. 10.3390/ijms2003063610.3390/ijms20030636 ↗
8. 10.2174/15680260878379090110.2174/156802608783790901 ↗
9. 10.1002/jbm.a.1042510.1002/jbm.a.10425 ↗
10. 10.1016/1054-8807(93)90054-610.1016/1054-8807(93)90054-6 ↗
11. 10.1089/ten.2005.11.110.1089/ten.2005.11.1 ↗
12. 10.1002/(SICI)1097-4636(20000315)49:4<435:AID-JBM2>3.0.CO;2-Y10.1002/(SICI)1097-4636(20000315)49:4<435:AID-JBM2>3.0.CO;2-Y ↗
13. 10.1002/jbm.1004310.1002/jbm.10043 ↗
14. 10.1021/acsami.9b0990010.1021/acsami.9b09900 ↗
15. 10.1002/adhm.20130053210.1002/adhm.201300532 ↗
16. 10.1007/s10856-006-0064-310.1007/s10856-006-0064-3 ↗
17. 10.1021/ja970819l10.1021/ja970819l ↗
18. 10.1007/s10856-006-0079-910.1007/s10856-006-0079-9 ↗
19. 10.1023/A:102495133026510.1023/A:1024951330265 ↗
20. 10.1016/0040-6090(92)90417-A10.1016/0040-6090(92)90417-A ↗
21. 10.1089/ten.TEB.2010.054810.1089/ten.TEB.2010.0548 ↗
22. 10.1021/ma980036010.1021/ma9800360 ↗
23. 10.1515/cdbme-2018-005310.1515/cdbme-2018-0053 ↗
24. 10.1016/S0142-9612(00)00181-210.1016/S0142-9612(00)00181-2 ↗
25. 10.1002/jbm.a.3031310.1002/jbm.a.30313 ↗
26. 10.1002/(SICI)1097-4636(20000605)50:3<281:AID-JBM1>3.0.CO;2-510.1002/(SICI)1097-4636(20000605)50:3<281:AID-JBM1>3.0.CO;2-5 ↗
27. 10.1016/j.actbio.2012.06.01010.1016/j.actbio.2012.06.010 ↗
28. 10.1163/15685620074422810.1163/156856200744228 ↗
29. 10.1021/acsmacrolett.7b0044810.1021/acsmacrolett.7b00448 ↗
30. 10.1002/food.1997041063110.1002/food.19970410631 ↗
31. 10.1002/jbm.a.1048210.1002/jbm.a.10482 ↗
32. 10.1016/j.regen.2021.10004710.1016/j.regen.2021.100047 ↗
33. 10.1155/2020/348154910.1155/2020/3481549 ↗
34. European Medicines Agency · 2011
35. U.S. Department of Health and Human Services, Food and Drug Administration · 2018
36. 10.1093/clinchem/27.3.49310.1093/clinchem/27.3.493 ↗
37. 10.1038/nbt.151110.1038/nbt.1511 ↗
38. 10.1038/nmeth.390110.1038/nmeth.3901 ↗
39. 10.1038/nature1009810.1038/nature10098 ↗
40. 10.1038/ncomms1285210.1038/ncomms12852 ↗
41. Saeed A. I. · 2006 · 411 · 134
42. 10.1159/00047566510.1159/000475665 ↗
43. 10.1371/journal.pone.007763410.1371/journal.pone.0077634 ↗
44. 10.1006/bbrc.2000.214310.1006/bbrc.2000.2143 ↗
45. 10.1080/096293503100013489710.1080/0962935031000134897 ↗
46. 10.1038/s41598-018-23755-y10.1038/s41598-018-23755-y ↗
47. 10.1177/175342590809917110.1177/1753425908099171 ↗
48. 10.1007/s00134-009-1609-y10.1007/s00134-009-1609-y ↗
49. 10.1038/s41590-019-0548-110.1038/s41590-019-0548-1 ↗
50. 10.1242/bio.20141090010.1242/bio.201410900 ↗
51. 10.1182/blood.v97.8.238110.1182/blood.v97.8.2381 ↗
52. 10.1016/s0021-9258(18)35698-910.1016/s0021-9258(18)35698-9 ↗
53. 10.1016/j.cellsig.2012.01.01810.1016/j.cellsig.2012.01.018 ↗
54. 10.3892/mmr.2018.854210.3892/mmr.2018.8542 ↗
55. 10.1002/jbm.a.3558710.1002/jbm.a.35587 ↗
56. 10.1021/acs.biomac.6b0042910.1021/acs.biomac.6b00429 ↗
57. 10.1515/bnm-2016-001510.1515/bnm-2016-0015 ↗
58. 10.1007/s00430-016-0449-y10.1007/s00430-016-0449-y ↗
59. 10.4049/jimmunol.110251410.4049/jimmunol.1102514 ↗
60. 10.1016/j.biomaterials.2006.01.01910.1016/j.biomaterials.2006.01.019 ↗
61. 10.1002/elps.20030582610.1002/elps.200305826 ↗
62. 10.1016/s0142-9612(02)00083-210.1016/s0142-9612(02)00083-2 ↗
63. 10.1189/jlb.031111010.1189/jlb.0311110 ↗
64. 10.1016/j.ccr.2010.11.00910.1016/j.ccr.2010.11.009 ↗
65. 10.1161/ATVBAHA.111.22274510.1161/ATVBAHA.111.222745 ↗
66. 10.1161/ATVBAHA.108.16869010.1161/ATVBAHA.108.168690 ↗
67. 10.1016/j.actbio.2014.03.03210.1016/j.actbio.2014.03.032 ↗
68. 10.1016/j.actbio.2019.06.02210.1016/j.actbio.2019.06.022 ↗
69. 10.1002/adfm.20180745310.1002/adfm.201807453 ↗
70. 10.1038/nri349510.1038/nri3495 ↗